Diagnostics and Tools April 2023

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

  • Epic Sciences, In. closed a $24mm Series A Financing, led by Domain Associates, L.L.C., Arsenal Capital Partners, Deerfield Management Company, L.P. Series C, Blue Ox Healthcare Partners, LLC, Labcorp Venture Fund
  • Mission Bio, Inc. closed a Series A Financing, led by Fulgent Genetics, Inc. (NasdaqGM:FLGT)
  • Sangon Biotech Engineering (Shanghai) Company Limited closed a $290.4mm Series A Financing, led by GL Capital Group, Greenwoods Investment, Huagai Capital Co., Ltd., CDB Technology Venture Capital Co., Ltd., CPE Yuanfeng, Beiguang Huagai Private Equity Fund Management (Beijing) Co., Ltd.

Download the BlueBook